Biote (BTMD) Revenue (2021 - 2026)

Biote (BTMD) has reported Revenue for 6 consecutive years, with $44.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Revenue fell 8.28% year-over-year to $44.9 million; the TTM figure through Mar 2026 stood at $188.2 million (down 5.63% YoY), while the FY2025 annual figure was $192.2 million, down 2.52% from the prior year.
• Revenue came in at $44.9 million for Q1 2026 at Biote, down from $46.4 million in the prior quarter.
• The five-year high for Revenue was $51.4 million in Q3 2024, with the low at $37.1 million in Q1 2022.
• Average Revenue over 5 years is $46.2 million, with a median of $46.4 million recorded in 2025.
• Across the five-year window, Revenue gained 20.73% in 2023 and fell 8.28% in 2026, its largest moves.
• Year by year, Revenue stood at $44.5 million in 2022, then rose by 2.74% to $45.7 million in 2023, then climbed by 9.04% to $49.8 million in 2024, then slipped by 6.87% to $46.4 million in 2025, then declined by 3.17% to $44.9 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $44.9 million, $46.4 million, and $48.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.